logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Trends & Strategies
  • Life Science & Technology Weekly 125 – Forum highlights investment in life science, high tech

Life Science & Technology Weekly 125 – Forum highlights investment in life science, high tech

Published on: Dec 14, 2017
Author: Editor
  • Share article:

Click here to find more details

This is NAI’s new Life Science and Technology Weekly. We will be covering the latest news in life science, pharmaceutical, biotech and technology sectors every week. To continue to receive NAI’s Life Science and Technology Weekly, please click Here to subscribe.

Biotechnology Life Science Technology

Related Posts

秃发患者的曙光?艾伯维新药让过半患者头皮毛发再生超80%

AbbVie’s Diversification Bet Gradually Shows Results, While Pfizer Seeks a Second Takeoff Through Its GLP-1 and Oncology Pipelines

多重利好因素下,台积电股价上涨近5%

TSMC’s Market Share Exceeds 70 Percent, Making It Irreplaceable, and Analysts Believe the Current Pullback Offers a Buying Opportunity

U.S. Launches ‘Prometheus’ AI Nuclear Initiative, With X-Energy, Oklo Among Partners

Restaurant Order Automation Drives High Growth: Can SoundHound AI Return to Its Peak?

Moderna’s 5x Surge Just Hit a Wall. Time to Buy or Bail?

Moderna’s 5x Surge Just Hit a Wall. Time to Buy or Bail?

OpenAI Declares the AGI Era, but This Risk Cannot Be Ignored

OpenAI Declares the AGI Era, but This Risk Cannot Be Ignored

辉瑞股票看起来是现在不二之选,主要原因已经揭晓

Pfizer Trades Below 10x P/E, But Does That Signal a Value Trap or a Long-Term Opportunity?

Related News

AbbVie’s Diversification Bet Gradually Shows Results, While Pfizer Seeks a Second Takeoff Through Its GLP-1 and Oncology Pipelines

2 days ago.

TSMC’s Market Share Exceeds 70 Percent, Making It Irreplaceable, and Analysts Believe the Current Pullback Offers a Buying Opportunity

2 days ago.

Restaurant Order Automation Drives High Growth: Can SoundHound AI Return to Its Peak?

2 days ago.

Strong Employment Persists While Inflation Remains Stubborn, September Rate Hike Odds Climb

2 days ago.

Top Stories

OpenAI Declares the AGI Era, but This Risk Cannot Be Ignored
Technology

OpenAI Declares the AGI Era, but This Risk Cannot Be Ignored

Tesla Gives Back All Its Gains as Cybercab Launch Raises More Questions Than Answers
Technology

Tesla Gives Back All Its Gains as Cybercab Launch Raises More Questions Than Answers

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada